Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Adeline Yeo"'
Autor:
Feng-Yu Li, Xin-Ee Tan, Yuzuki Shimamori, Kotaro Kiga, Srivani Veeranarayanan, Shinya Watanabe, Yutaro Nishikawa, Yoshifumi Aiba, Yusuke Sato’o, Kazuhiko Miyanaga, Teppei Sasahara, Sarah Hossain, Kanate Thitiananpakorn, Tomofumi Kawaguchi, Huong Minh Nguyen, Adeline Yeo Syin Lian, Sharmin Sultana, Ola Alessa, Geoffrey Kumwenda, Jayathilake Sarangi, Jastin Edrian Cocuangco Revilleza, Priyanka Baranwal, Mohammad Omar Faruk, Yuya Hidaka, Myat Thu, Mahmoud Arbaah, Anujin Batbold, Maniruzzaman, Yi Liu, Ho Thi My Duyen, Takashi Sugano, Nayanjin Tergel, Takayuki Shimojyo, Longzhu Cui
Publikováno v:
Communications Biology, Vol 7, Iss 1, Pp 1-11 (2024)
Abstract In response to the escalating antibiotic resistance in multidrug-resistant pathogens, we propose an innovative phagemid-based capsid system to generate CRISPR-Cas13a-loaded antibacterial capsids (AB-capsids) for targeted therapy against mult
Externí odkaz:
https://doaj.org/article/bb362cf4ba624f929db8a29a2ce1e489
Autor:
Yuzuki Shimamori, Xin-Ee Tan, Feng-Yu Li, Yutaro Nishikawa, Shinya Watanabe, Teppei Sasahara, Kazuhiko Miyanaga, Yoshifumi Aiba, Srivani Veeranarayanan, Kanate Thitiananpakorn, Huong Minh Nguyen, Anujin Batbold, Tergel Nayanjin, Adeline Yeo Syin Lian, Sarah Hossain, Tomofumi Kawaguchi, Ola Alessa, Geofrey Kumwenda, Jayathilake Sarangi, Jastin Edrian C. Revilleza, Priyanka Baranwal, Mahmoud Arbaah, Maniruzzaman, Liu Yi, Ho Thi My Duyen, Takashi Sugano, Sharmin Sultana, Mohammad Omar Faruk, Yuya Hidaka, Myat Thu, Takayuki Shimojyo, Kotaro Kiga, Longzhu Cui
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-10 (2024)
Abstract In response to the escalating global threat of antimicrobial resistance, our laboratory has established a phagemid packaging system for the generation of CRISPR-Cas13a-antimicrobial capsids targeting methicillin-resistant Staphylococcus aure
Externí odkaz:
https://doaj.org/article/89e20191ded34cbbb0f51b583319b39a
Autor:
Shinya Watanabe, Chijioke A. Nsofor, Kanate Thitiananpakorn, Xin-Ee Tan, Yoshifumi Aiba, Remi Takenouchi, Kotaro Kiga, Teppei Sasahara, Kazuhiko Miyanaga, Srivani Veeranarayanan, Yuzuki Shimamori, Adeline Yeo Syin Lian, Thuy Minh Nguyen, Huong Minh Nguyen, Ola Alessa, Geoffrey Peterkins Kumwenda, Sarangi Jayathilake, Jastin Edrian Cocuangco Revilleza, Priyanka Baranwal, Yutaro Nishikawa, Feng-Yu Li, Tomofumi Kawaguchi, Sowmiya Sankaranarayanan, Mahmoud Arbaah, Yuancheng Zhang, Maniruzzaman , Yi Liu, Hossain Sarah, Junjie Li, Takashi Sugano, Thi My Duyen Ho, Anujin Batbold, Tergel Nayanjin, Longzhu Cui
Publikováno v:
mBio, Vol 15, Iss 6 (2024)
ABSTRACT The emergence of oxacillin-susceptible methicillin-resistant Staphylococcus aureus (OS-MRSA) has imposed further challenges to the clinical management of MRSA infections. When exposed to β-lactam antibiotics, these strains can easily acquir
Externí odkaz:
https://doaj.org/article/547c4e4b793543ea887abfa483f64280
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Su-Peng Yeh, Po Nan Wang, Johan Maertens, Liang Piu Koh, Armin Gerbitz, Peter Pertel, John W. Hiemenz, Kristin Smith, Adeline Yeo, Junho Jang, Gwynn D. Long, Florencia Segal, Julia Winkler, Ernst Holler, Sangana Ramachandra, Stephan Mielke, Dong-Gun Lee, Aaron C Logan, Roy F. Chemaly, William Hwang, Jih-Luh Tang, Sandra Christoph, Luke Akard
Publikováno v:
Antimicrobial Agents and Chemotherapy
Antimicrobial agents and chemotherapy, vol 64, iss 4
Antimicrobial agents and chemotherapy, vol 64, iss 4
Human cytomegalovirus (HCMV) can cause significant disease in immunocompromised patients, and treatment options are limited by toxicities. CSJ148 is a combination of two anti-HCMV human monoclonal antibodies (LJP538 and LJP539) that bind to and inhib
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f9eb0b33c733690b773c45ed7171c1cf
https://lirias.kuleuven.be/handle/20.500.12942/687544
https://lirias.kuleuven.be/handle/20.500.12942/687544
Autor:
Suzanne F. Jones, Daphne L. Farrington, Maciej J. Zamek-Gliszczynski, Jennifer F. Cooksey, Kimberley Jackson, Jhanelle E. Gray, Adeline Yeo, Kay H. Chow, George R. Simon, Les H. Brail, Jeffrey R. Infante, Howard A. Burris
Publikováno v:
Investigational New Drugs. 33:1187-1196
Purpose LY2090314 (LY) is a glycogen synthase kinase 3 inhibitor with preclinical efficacy in xenograft models when combined with platinum regimens. A first-in-human phase 1 dose-escalation study evaluated the combination of LY with pemetrexed/carbop
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::52002e2eecbdaf949ffdd28a885cce93
https://doi.org/10.1007/s10637-015-0278-7
https://doi.org/10.1007/s10637-015-0278-7
Autor:
Adeline Yeo, Helle Linnebjerg, Prajakti A. Kothare, Maggie Lim, Soomin Park, Stephen D. Wise, Kenneth F. Mace, Danny Soon, Clark Chan
Publikováno v:
The Journal of Clinical Pharmacology. 45:1032-1037
This open-label study investigated the effect of exenatide coadministration on the steady-state plasma pharmacokinetics of digoxin. A total of 21 healthy male subjects received digoxin (day 1, 0.5 mg twice daily; days 2-12, 0.25 mg once daily) and ex
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6679415294fa4ebf04c93a13396e3b96
https://doi.org/10.1177/0091270005278806
https://doi.org/10.1177/0091270005278806
Publikováno v:
Genomics. 84:767-777
Affymetrix's high-density oligonucleotide arrays offer an exciting technology in biomedical research. With more and more statistical involvement in every step of the process, there has been a constant effort to make sure that the expression data are
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9eef15d794d90761ed4757f1238cc4d8
https://doi.org/10.1016/j.ygeno.2004.06.013
https://doi.org/10.1016/j.ygeno.2004.06.013
Autor:
Adeline Yeo, Yongming Qu
Publikováno v:
Pharmaceutical statistics. 8(1)
It is challenging to estimate the statistical power when a complicated testing strategy is used to adjust for the type-I error for multiple comparisons in a clinical trial. In this paper, we use the Bonferroni Inequality to estimate the lower bound o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::783965890c2e5945479036c2a18b7729
https://pubmed.ncbi.nlm.nih.gov/18381588
https://pubmed.ncbi.nlm.nih.gov/18381588